Ovid Therapeutics Inc. - COM (OVID)

Historical Portfolio Holders from Q2 2017 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
38.8M
Holdings value Q3 2024
$45.8M
Value change Q3 2024
-$2.31M
Grand Portfolio weight change Q3 2024
0%
Number of holders
74
Number of buys Q3 2024
37
Number of sells Q3 2024
-23
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 38.8M $45.8M -$2.31M $1.18 75
2024 Q2 38.5M $29.6M -$20.9M $0.77 72
2024 Q1 42.6M $130M -$4.73M $3.05 79
2023 Q4 44.1M $142M +$8.16M $3.22 76
2023 Q3 42.3M $163M +$5.68M $3.84 64
2023 Q2 41M $135M +$8.71M $3.28 69
2023 Q1 38.7M $99.8M +$651K $2.58 60
2022 Q4 38.6M $71.7M +$2.58M $1.86 58
2022 Q3 35.6M $65.5M +$1.72M $1.84 56
2022 Q2 34.6M $74.5M -$3.01M $2.15 54
2022 Q1 35.1M $110M +$3.43M $3.14 61
2021 Q4 34M $109M +$1.24M $3.21 65
2021 Q3 33.6M $113M -$90.8K $3.36 70
2021 Q2 33.4M $130M -$11M $3.91 76
2021 Q1 36.3M $146M +$42.6M $4.02 85
2020 Q4 27.4M $63.3M -$6.38M $2.31 75
2020 Q3 25.1M $144M +$11.1M $5.74 92
2020 Q2 21.8M $161M +$48.7M $7.37 79
2020 Q1 15.8M $47.1M -$7.21M $2.98 55
2019 Q4 17.8M $73.7M +$38.3M $4.15 58
2019 Q3 8.21M $26.6M -$5.12M $3.24 37
2019 Q2 10.1M $18.7M -$3.71M $1.85 33
2019 Q1 12.3M $21.7M +$9.09M $1.77 47
2018 Q4 6.84M $16.5M -$8.21M $2.42 46
2018 Q3 7.39M $41.9M -$3.04M $5.67 49
2018 Q2 7.65M $59.7M +$4.81M $7.80 47
2018 Q1 7.05M $49.8M -$9.28M $7.07 48
2017 Q4 7.82M $77.2M +$5.98M $9.87 49
2017 Q3 7.22M $61.5M -$6.77M $8.57 42
2017 Q2 7.96M $81.5M +$81.5M $10.49 42